HCID 86611628, compound → HCID 16067807, compound
Reaction equation
[F:1][CH:2]([F:31])[C:3]1[N:8]2[N:9]=[CH:10][C:11]([C:12](O)=O)=[C:7]2[N:6]=[C:5]([C:15]2[CH:20]=[CH:19][C:18]([C:21]([F:24])([F:23])[F:22])=[C:17]([O:25][CH2:26][C:27]([F:30])([F:29])[F:28])[CH:16]=2)[CH:4]=1.[NH2:32][C:33]1[CH:42]=[CH:41][C:36]([C:37]([NH:39][OH:40])=[NH:38])=[CH:35][N:34]=1>>[F:31][CH:2]([F:1])[C:3]1[N:8]2[N:9]=[CH:10][C:11]([C:12]3[O:40][N:39]=[C:37]([C:36]4[CH:41]=[CH:42][C:33]([NH2:32])=[N:34][CH:35]=4)[N:38]=3)=[C:7]2[N:6]=[C:5]([C:15]2[CH:20]=[CH:19][C:18]([C:21]([F:22])([F:23])[F:24])=[C:17]([O:25][CH2:26][C:27]([F:30])([F:29])[F:28])[CH:16]=2)[CH:4]=1Participants
3
Procedure
The title compound was prepared from 7-difluoromethyl-5-[3-(2,2,2-trifluoro-ethoxy)-4-trifluoromethyl-phenyl]-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (example C. 14) (228 mg, 0.5 mmol) and 6-amino-N-hydroxy-nicotinamidine (example B.4) (114 mg, 0.75 mmol) according to general procedure II. Obtained after flash chromatography on silica gel (ethyl acetate/heptane) and further purification by crystallization (dichloromethane/hexane) as a yellow solid (125 mg, 44%). MS (ISP) 572.1 [(M+H)+]; mp 285° C.
Workup
- customObtained after flash chromatography
- customon silica gel (ethyl acetate/heptane) and further purification
- customby crystallization (dichloromethane/hexane) as a yellow solid (125 mg, 44%)
Sources & evidence
- ORD record
- ord-4ec3763c3f1b41aaab2e35be8ddea0fd
- Source dataset
- uspto-grants-2009_03
- Patent number
- US07504404B2
Reaction notes
Loading…